Hims and Hers Health Inc vs Wahed FTSE USA Shariah ETF — how do they compare? Hims and Hers Health Inc trades at $30.71 (market cap $7.12B), while Wahed FTSE USA Shariah ETF trades at $72.95. The key difference: Wahed FTSE USA Shariah ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | HLAL | |
|---|---|---|
Market Cap | $7.12B | — |
Sector | Health | Sector/Thematic |
52-Week High | $62.76 | $73.60 |
52-Week Low | $14.52 | $55.52 |
Enterprise Value | $7.82B | — |
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $30.00, down 5.57% amid mixed Q2 2026 results. Revenue growth remains strong, with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a wider-than-expected quarterly loss. Technical indicators are neutral to bearish, with the price near key support at $30. Recent news highlights an FTC investigation and class-action lawsuits as headwinds.
The investment outlook is cautious. Growth prospects from subscriber gains and AI integration are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33.00 price target, suggesting limited near-term upside amid profitability concerns and negative free cash flow trends.
HLAL trades at $72.95, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bullish trend based on moving averages, though oscillators are neutral. The stock lacks recent fundamental data, with key ratios like P/E and P/S unavailable. A small dividend of $0.02 is scheduled for June 2026, but no recent earnings or cash flow updates are present.
The outlook is mixed due to incomplete financials; technical strength suggests potential upside, but fundamental opacity poses risks. Investors face uncertainty without current revenue or profit metrics, requiring caution until updated SEC filings or analyst reports emerge to assess valuation and growth prospects accurately.
Trailing returns across standard periods
Latest headlines on both assets
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →HLAL is an ETF that invests in Shariah-compliant US companies. It follows a rigorous screening process to exclude businesses involved in non-compliant activities like interest-based finance, alcohol, and gambling.
Read more on HLAL →